Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Boldrini

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Carcinogenesis|March 1, 1994
3T3 NIH murine fibroblasts and B78 murine melanoma cells expressing the Escherichia coli N3-methyladenine-DNA glycosylase I do not become resistant to alkylating agentsL Imperatori, G Damia, P Taverna, et al.
RSC Advances|April 15, 2022
Dye-catalyst dyads for photoelectrochemical water oxidation based on metal-free sensitizersCristina Decavoli, Chiara L Boldrini, Vanira Trifiletti, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 11, 2020
Spatially fractionated radiotherapy (SFRT) targeting the hypoxic tumor segment for the intentional induction of non-targeted effects: An <i>in silico</i> study to exploit a new treatment paradigmM Massaccesi, L Boldrini, A Piras, et al.
International Journal of Oncology|May 11, 2006
Telomerase activity and hTERT mRNA expression in glial tumorsL Boldrini, S Pistolesi, S Gisfredi, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 25, 2021
Dosimetric accuracy of dual isocenter irradiation in low magnetic field resonance guided radiotherapy system for extended abdominal tumoursL Placidi, M Nardini, D Cusumano, et al.
Pathology Oncology Research : POR|October 26, 2018
C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer?L Boldrini, R Bartoletti, M Giordano, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 18, 2021
Process mining to optimize palliative patient flow in a high-volume radiotherapy departmentL Placidi, L Boldrini, J Lenkowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinomaG Fontanini, S Vignati, L Boldrini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular densityG Fontanini, L Boldrini, A Calcinai, et al.
International Journal of Oncology|December 24, 1998
Quantitation by competitive PCR assay of vascular endothelial growth factor in non-small cell lung carcinomasL Boldrini, A Calcinai, V Silvestri, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Carcinogenesis|March 1, 1994
3T3 NIH murine fibroblasts and B78 murine melanoma cells expressing the Escherichia coli N3-methyladenine-DNA glycosylase I do not become resistant to alkylating agentsL Imperatori, G Damia, P Taverna, et al.
RSC Advances|April 15, 2022
Dye-catalyst dyads for photoelectrochemical water oxidation based on metal-free sensitizersCristina Decavoli, Chiara L Boldrini, Vanira Trifiletti, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 11, 2020
Spatially fractionated radiotherapy (SFRT) targeting the hypoxic tumor segment for the intentional induction of non-targeted effects: An <i>in silico</i> study to exploit a new treatment paradigmM Massaccesi, L Boldrini, A Piras, et al.
International Journal of Oncology|May 11, 2006
Telomerase activity and hTERT mRNA expression in glial tumorsL Boldrini, S Pistolesi, S Gisfredi, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 25, 2021
Dosimetric accuracy of dual isocenter irradiation in low magnetic field resonance guided radiotherapy system for extended abdominal tumoursL Placidi, M Nardini, D Cusumano, et al.
Pathology Oncology Research : POR|October 26, 2018
C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer?L Boldrini, R Bartoletti, M Giordano, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 18, 2021
Process mining to optimize palliative patient flow in a high-volume radiotherapy departmentL Placidi, L Boldrini, J Lenkowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinomaG Fontanini, S Vignati, L Boldrini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular densityG Fontanini, L Boldrini, A Calcinai, et al.
International Journal of Oncology|December 24, 1998
Quantitation by competitive PCR assay of vascular endothelial growth factor in non-small cell lung carcinomasL Boldrini, A Calcinai, V Silvestri, et al.
Pageof 7